Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Subbiah

Showing results (161-170 of 487) with videos related to

Pageof 49
Sort By:
Journal of the National Cancer Institute|November 9, 2017
Co-occurring Genomic Alterations and Association With Progression-Free Survival in BRAFV600-Mutated Nonmelanoma TumorsShiraj Sen, Funda Meric-Bernstam, David S Hong, et al.
Cancer Treatment Reviews|April 2, 2021
Immunotherapy in non-small cell lung cancer harbouring driver mutationsAlfredo Addeo, Antonio Passaro, Umberto Malapelle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
<i>RET</i> Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 PatientsShumei Kato, Vivek Subbiah, Erica Marchlik, et al.
NPJ Precision Oncology|June 8, 2021
The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinibTao Shen, Xueqing Hu, Xuan Liu, et al.
Current Treatment Options in Oncology|June 18, 2009
Ewing's sarcoma: standard and experimental treatment optionsVivek Subbiah, Pete Anderson, Alexander J Lazar, et al.
Experimental Hematology|June 14, 2008
Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopeniaVivek Subbiah, Aaron D Viny, Steven Rosenblatt, et al.
Oncoscience|September 22, 2023
Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgeryMohamed A Gouda, Filip Janku, Neeta Somaiah, et al.
Nature Reviews. Clinical Oncology|September 25, 2021
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatmentAlex Friedlaender, Vivek Subbiah, Alessandro Russo, et al.
Journal of Pediatric Hematology/Oncology|February 20, 2010
99mTc-sestamibi scan differentiates tumor from other contrast enhancing tissue in choroid plexus tumorsVivek Subbiah, Leena Ketonen, Janet M Bruner, et al.
Oncoscience|August 8, 2017
Next generation sequencing of carcinoma of unknown primary reveals novel combinatorial strategies in a heterogeneous mutational landscapeIshwaria M Subbiah, Apostolia Tsimberidou, Vivek Subbiah, et al.
Pageof 49

Showing results (161-170 of 487) with videos related to

Sort By:
Pageof 49
Journal of the National Cancer Institute|November 9, 2017
Co-occurring Genomic Alterations and Association With Progression-Free Survival in BRAFV600-Mutated Nonmelanoma TumorsShiraj Sen, Funda Meric-Bernstam, David S Hong, et al.
Cancer Treatment Reviews|April 2, 2021
Immunotherapy in non-small cell lung cancer harbouring driver mutationsAlfredo Addeo, Antonio Passaro, Umberto Malapelle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
<i>RET</i> Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 PatientsShumei Kato, Vivek Subbiah, Erica Marchlik, et al.
NPJ Precision Oncology|June 8, 2021
The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinibTao Shen, Xueqing Hu, Xuan Liu, et al.
Current Treatment Options in Oncology|June 18, 2009
Ewing's sarcoma: standard and experimental treatment optionsVivek Subbiah, Pete Anderson, Alexander J Lazar, et al.
Experimental Hematology|June 14, 2008
Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopeniaVivek Subbiah, Aaron D Viny, Steven Rosenblatt, et al.
Oncoscience|September 22, 2023
Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgeryMohamed A Gouda, Filip Janku, Neeta Somaiah, et al.
Nature Reviews. Clinical Oncology|September 25, 2021
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatmentAlex Friedlaender, Vivek Subbiah, Alessandro Russo, et al.
Journal of Pediatric Hematology/Oncology|February 20, 2010
99mTc-sestamibi scan differentiates tumor from other contrast enhancing tissue in choroid plexus tumorsVivek Subbiah, Leena Ketonen, Janet M Bruner, et al.
Oncoscience|August 8, 2017
Next generation sequencing of carcinoma of unknown primary reveals novel combinatorial strategies in a heterogeneous mutational landscapeIshwaria M Subbiah, Apostolia Tsimberidou, Vivek Subbiah, et al.
Pageof 49